Distribution Services · Medical Distributors · NSE: ENTERO · data 2026-10-09

Entero Healthcare Solutions Limited

Health check: Average (5.9/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹1,676.2

Market cap

₹7,344 cr

P/E

58.2

P/B

—

ROE

6.7%

ROCE

11.6%

Debt / equity

0.4

Dividend yield

0.00%

1-year return

45.9%

52-week high

₹1,920

52-week low

₹944

Operating margin

3.7%

Growth

Revenue (last 12 months)	₹7,128 cr
Net profit (last 12 months)	₹125 cr
Sales growth, 3 years (yearly)	25.9%
Profit growth, 3 years (yearly)	—

Chart patterns

Double top — forming (key level ₹1,610.8)
Descending triangle — forming (key level ₹1,610.8)

Similar companies

QMS Medical Allied Services Limited (QMSMEDI) · Vijaypd Ceutical Limited (VIJAYPD) · Balaxi Pharmaceuticals Limited (BALAXI) · Aakaar Medical Technologies Limited (AAKAAR) · Vivo Bio Tech Ltd. (VIVOBIOT)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open ENTERO in NSE Scanner →